FDA Drugs (New Approvals & NDA)Original article
Drug Repurposing: Considerations for Selection Criteria and Prioritization - 08/05/2026
ConferenceNeutral
AI Analysis
Summary
The Reagan-Udall Foundation for the FDA will hold a hybrid public meeting on August 5, 2026, to discuss opportunities for identifying new uses of FDA-approved drugs to expand patient treatment options.
Importance:2/10
Sentiment:
0.00
drug repurposingFDApublic meetingtreatment options
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on July 9, 2026 5:03 PM